Cystatin C: A new cardiovascular risk marker?;Cistatina C: ¿un nuevo marcador de riesgo cardiovascular?

Medicina Clinica

Volumn 130, Issue 1, 2008, Pages 13-14

  Méndez Bailón, Manuel ^a   Mena, Luis Audibert ^a  

^a HOSPITAL GENERAL UNIVERSITARIO GREGORIO MARAÑÓN   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; CYSTATIN C; CYSTATIN;

CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; EDITORIAL; HUMAN; RISK ASSESSMENT; RISK FACTOR; ARTICLE; BLOOD;

BIOLOGICAL MARKERS; CARDIOVASCULAR DISEASES; CYSTATINS; HUMANS; RISK FACTORS;

EID: 38349188470     PISSN: 00257753     EISSN: 15788989     Source Type: Journal    
DOI: 10.1157/13114561     Document Type: Editorial

References (11)

1. Go A, Chertow G, Fan D, McCulloch CE, Hsu CY. Chronic kidney disease and risks of death, cardiovascular events, and hospitalization. N Engl J Med. 2004;351:1296-305.
2. National Kidney Foundation. K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Dis. 2002;39 Suppl 1:S1-S266.
3. Sarnak MJ, Levey AS, Schoolwerth AC, Coresh J, Culleton B, Hamm LL, et al. Kidney disease as a risk factor for development of cardiovascular disease. Circulation. 2003;108:2154-69.
4. Stevens LA, Levey AS. Clinical implications for estimating equations for glomerular filtration rate. Ann Intern Med. 2004;141:959-61.
5. Grubb AO. Cystatin C - properties and use as diagnostic marker. Adv Clin Chem. 2000;35:63-99.
6. Hoek FJ, Kemperman FA, Krediet RT. A comparison between cystatin C, plasma creatinine and the Cockcroft and Gault formula for the estimation of glomerular filtration rate. Nephrol Dial Transplant. 2003;18:2024-31.
7. Knight EL, Verhave JC, Spiegelman D, Hillege HL, De Zeeuw D, Curhan GC, et al. Factors influencing serum cystatin C levels other than renal function and the impact on renal function measurement. Kidney Int. 2004;65:1416-21.
8. Shlipak MG, Sarnak MJ, Katz R, Fried LF, Seliger SL, Newman AB, et al. Cystatin C and the risk of death and cardiovascular events among elderly persons. N Engl J Med. 2005;352:2049-60.
9. Ix JH, Shlipak MG, Chertow GM, Whooley MA. Association of Cystatin C With Mortality, Cardiovascular Events, and Incident Heart Failure Among Persons With Coronary Heart Disease: Data From the Heart and Soul Study. Circulation. 2007;115:173-9.
10. Méndez Bailón M, Romero Román C, Conthe Gutiérrez P, Audibert Mena L. Determinación de cistatina C en pacientes de edad avanzada con insuficiencia cardíaca. Med Clin (Barc). 2006;127:636.
11. Rodilla E, Costa JA, Pérez Lahiguera F, González C, Miralles A, Pascual JM. Relación del cistatina C con otros parámetros de riesgo vascular en pacientes con hipertensión arterial. Med Clin (Barc). 2008;130:6-9.